The table below features the cord lining/tissue releases performed by Cordlife Group Limited and its subsidiaries.
As a Group, Cordlife has made 19 cord lining/tissue releases, all of which have been used successfully in cellular therapy.
NO | RELEASE | MEDICAL CONDITION | RECIPIENT'S RELATIONSHIP | STORAGE TIME (in months) | TREATMENT FACILITY |
---|
Some releases may be for the same client but released in different period.
Cordlife is proud to help these families in using their cord blood/cord lining/ tissues units stored in various Cordlife facilities for successful stem cell transplantation.

Joyce
Joyce's parents were over the moon when they welcomed their baby girl into the world. They watched her grow, smiling at each new milestone she reached. However, when Joyce was just seven months old, their world came crashing down when she was diagnosed with hypoxic-ischemic encephalopathy.
Joyce had heart surgery to treat an underlying heart problem when she was six months old. The surgery caused oxygen deprivation in her brain, resulting in its shrinkage by 3%. She was unresponsive to external stimuli and had limited consciousness. Her parents were heartbroken that she had to deal with such a condition at such a young age, but they never gave up hope, even when doctors and specialists told them that her condition was incurable.
They searched for possible cures online and stumbled upon research papers and clinical trials that showed how cord blood infusion could help. They remembered that they had stored Joyce's cord blood with Cordlife Hong Kong when she was born and immediately reached out to Cordlife.
After receiving the request from Joyce's parents, the team at Cordlife Hong Kong immediately got in touch with the medical team, which decided to perform the cord blood infusion at the Hong Kong Children's Hospital. The procedure went smoothly, and Joyce did not feel any pain or have any negative side effects. The doctors gave Joyce a good prognosis, and she started to show signs of improvement soon after the infusion.
Joyce's vision improved, and she could now follow the source of light. Even though she still requires tube feeding, her ability to swallow has improved, and she can now swallow her own saliva. She also has more varied and frequent hand and foot movements, and her mental state improved significantly. Thanks to Cordlife's Transplant Care, which is an insurance benefit in the cord blood banking service agreement, the insurance payout helped ease her parents' financial burden, allowing them to focus more on Joyce's recovery.
Joyce has since been discharged from the hospital, and her parents believe that if financial resources allow, all parents should store their baby's precious cord blood. Cord blood can potentially be used to treat more than 80 diseases, such as blood cancers, blood disorders, and genetic diseases. If a child's cord blood was saved, it could be used to treat him/her and his/her family in the event of a health crisis.
Jayant Chabra
Jaisheel and Archana Chabra, a couple from Meerut, were living a happy life with their daughter like any other family. On the 29th of October, 2016, the family was blessed with a baby boy named Jayant Chabra. Jayant's cord blood was preserved with Cordlife at the moment of delivery. And everything went according to plan. With God’s grace, their family picture has been completed with the arrival of their younger son. The child appeared to be completely normal.
However, the problem began four months after Jayant's birth, when the parents observed that their son was having some challenges that appeared to be significant, and they immediately sought medical advice. The doctor suggested certain tests, and when the results came out, he advised them to get some more blood tests done. The family's entire world was turned upside down when the blood test reports arrived.
The reports suggested that Jayant was suffering from Thalassaemia Major which is a genetic disorderthat occurs due to thedestruction of the red cells of the blood.
The couple had heard of the disorder but had no clue that how come this disorder being detected in their kid and how do they deal with it now. Further tests had been done as per the recommendation of their doctor and the results confirmed that the baby was suffering from Major Thalassaemia at the age of 5 months.
Because they had previously saved their Baby's cord blood unit with Cordlife, they were on their way to find a means to find a cure to the disorder the child was experiencing.During pregnancy with Jayant, his parents contacted Cordlife and had a brief discussion for 4-5 months about the services and benefits of Cord Blood banking and how it could be a life saver in the future if the need arose. They went on to preserve his cord blood with Cordlife.When the child was diagnosed with Thalassaemia, it was time for his parents to return to Cordlife, where his Cord Blood stem cells were stored.The father wrote to Cordlife to explain the dilemma they are in and to seek a solution. Cordlife assured him that they are there for the family and will assist them in any manner possible in accordance with the agreement for the child's treatment. In case of requirement Cordlife will procure the stem cells too by using its best endeavours from the public the bank in case the need arises for the transplantation.
At the time of transplantation Cordlife had sourced the matched stem cell unit for the kid from public repository. The cost of the treatment was very high till 40-45 lakhs. In which Cordlife helped them with that too. Cordlife had provided the client with the financial assistance from the insurance provider as promised.
The transplantation has been successful and the child recovering well.. After 5 years they were relieved and now their kid is living a healthy life.
Cordlife not only promised, but actually followed through on the words it did include in the agreement.As the mother of the kid rightly said - no one has seen the future. But in case the future puts your family in such a challenging situation, you need to have a weapon to deal with it and save your families future. This is an eye opener for all expectant parent and will help them to make the right decision of preserving their baby’s cord blood at the time of birth with Cordlife. So that in near future, god forbids, if any family face such adverse situation, Cordlife will support and help the family using the best possible endeavours as promised.
Video Link: https://www.youtube.com/watch?v=tXh-ivKyks0

Eugene
Eugene (not his real name) was diagnosed with leukaemia and doctors had given him only 10 per cent chance of recovery, unless he undergoes a bone marrow transplant. However, neither of his parents are a match and as an only child, he had a one in 20,000 chance of finding a non-related donor.
“We came across articles on how cord blood stem cells had been used to treat various blood-related disorders, including leukaemia,” said Eugene’s parents. “Cord blood stem cells also had a higher chance of successful matching as compared to bone marrow. We decided to conceive a second child and use the cord blood to save our son.”
In mid-2002, Eugene’s mother was found to be pregnant with a second child and they decided to store their baby’s precious cord blood with Cordlife. The baby’s cord blood was found to be a 100 per cent match for Eugene, which meant that not only could the cord blood be used, the transplant would also have a higher chance of success. The healthy cells from his sibling repopulated in his bone marrow and revived his immune system, that was previously depleted by the chemotherapy and radiotherapy used to treat the leukaemia.
“Eugene is doing very well now at home. He just started school and is enjoying every minute of it. We still need to be careful and make sure he does not tire himself out, but this is nothing compared to those dark days when he was really sick. The decision to collect his sister’s cord blood was the right one.” said Eugene’s mother.

Harumi
“We refused to give up,” said Mr. Hasan and Mrs. Dwi Aprilia as they recalled the time when they found out that their daughter Harumi has cerebral palsy. This proclamation was the source of strength that kept this couple fighting on to nurse their baby back to health.
Nothing unusual happened during Harumi’s birth. Everything seemed fine. Yet, at only a few days old, the little baby experienced her first seizure. The first month of Harumi’s life was the hardest because her parents could not figure out what was happening to their baby daughter. She was only finally diagnosed with cerebral palsy after the family consulted several doctors. Harumi's parents had few options then. Someone told them to accept the reality but they insisted on not giving up and continued to tirelessly search for possible solutions to help their daughter.
When Harumi was born, her parents donated her umbilical cord to a laboratory owned by a friend. Under the advice of this friend, Harumi underwent her first stem cell therapy with stem cells obtained from her own umbilical cord. She was almost three months old at the time. After the therapy, Harumi's condition improved and she had lesser seizure episodes, which stopped eventually.
As Harumi's umbilical cord was not stored under optimal conditions, she only had enough stem cells for one infusion. While Mr. Hasan and Mrs. Dwi continued to search for other viable options, they put Harumi on regular physiotherapy to help develop her sensory and motor functions.
Five months later, a blessing came knocking on the family's door when Mrs. Dwi became pregnant with their second child. Encouraged by the positive result from using Harumi's umbilical cord stem cells, the couple decided to store their second child’s umbilical cord blood and umbilical cord lining as well. This time around, they selected a more well-established stem cell bank - Cordlife - to safeguard their baby son's precious biological resources.
A few months after Harumi turned two, she went through another stem cell therapy using her baby brother’s umbilical cord stem cells, collected and cryopreserved by Cordlife. This time, her parents noticed that Harumi's eyes can properly align with each other and she can visually follow light movements with ease.
The couple's undying perseverance in seeking help for their beloved daughter proved to be fruitful. Although Harumi still requires more interventions, the progress in her health and development gave hope to her parents.
For Mr. Hasan and Mrs. Dwi, Harumi’s unexpected predicament is a constant reminder not take things for granted and to do whatever they can within their means to safeguard their children's health. They also encourage parents of children with cerebral palsy not to give up. “No matter how big or small the chance is, every effort has its own fruit. And maybe, among the efforts, a miracle is waiting to be found,” said the couple.

Ching
Ching (alias) was diagnosed with Thalassemia Major. As a result, blood transfusion became part of her life. In attempt to free Ching of her suffering, her mother decided to meet Cordlife’s consultants to learn how cord blood can help Ching’s life. Luckily, doctors successfully performed a cord blood transplant when Ching was 5 years old at Hong Kong Queen Mary Hospital. Recovering swiftly, Ching is just like any other ordinary girls that enjoys school life.

Ee Han
When little Ee Han was 3 months old, his parents noticed that his neck was soft and could not hold his own head. He was then diagnosed with growth development delay and quadriplegic cerebral palsy. His ENT doctor also confirmed that he was suffering from severe hearing loss in both ears.
Since then, little Ee Han has been undergoing multiple therapies and depending on mobility and hearing aids to improve the quality of his life. At an Early Intervention Programme for Infants & Children (EIPIC) class outing, Ee Han’s parents chanced upon another child suffering from a similar condition who had improved tremendously after an infusion of his own cord blood. This encouraged them to let little Ee Han go through a cord blood infusion since they had stored his cord blood with Cordlife at birth.
In November 2014 and September 2015, Ee Han went through two rounds of cord blood infusion performed by Dr Keith Goh, Consultant Neurosurgeon from Mount Elizabeth Hospital. Each round took no more than 45 minutes to complete. After the infusions, both Dr Goh and Ee Han’s parents noted visible improvements including faster sitting up movements and better control of his emotions.
I noticed that Ee Han’s motor skills has improved and he now has more strength and control of his limbs. He can even walk with support. Ee Han is now more responsive and cognitively aware of things.
said Dr Keith Goh.

Kamsiyochukwu Bryan Peter Ezenwa
At the age of 2, Kamsiyochukwu was diagnosed with Sickle Cell Anaemia, a dreadful inherited blood disorder which affects the haemoglobin. Subject to multiple transfusions as part of the conventional treatment led to several complications which further deteriorated his health. Seeing their child’s critical condition, his parents were searching for a permanent cure to this pain and suffering. When they learnt that Cord Blood transfusion could help their child to get rid of this suffering, they planned for another baby in India and on the suggestion of their doctor, stored their 2nd child’s cord blood.
On 21st January, 2020, 8yr old Kamsiyochukwu underwent the transplantation at Apollo Hospital, India with his sibling’s Cord Blood Stem Cells. Before the transplantation, he underwent Chemotherapy to prepare his body for the cord blood transfusion. There were no adverse effects observed throughout the process and the transplant was declared successful. And since the transplant, Kamsiyochukwu has been okay and is leading painless life, back at their native - Nigeria.
Kamsiyochukwu’s mother, Blessing Ezenwa applauded Cordlife for not only safekeeping and timely delivery of the Cord Blood sample to the transplant centre at the time of need, but also for the financial insurance provided by Cordlife at the time of transplant. Ever since the transplant, little Kamsiyochukwu has been thankful to Cordlife for the new lease of life he received from his sibling’s cord blood.

Moinam
Moinam was diagnosed Thalassamia when he was barely one year old. If left untreated, most of the children inflicted with this disorder do not live beyond the age of 10. Fortuitously, his newborn sister was free from Thalassamia and her cord blood stem cells were a perfect match for Moinam, with small amount of bone marrow to supplement the transplant, Moinam is now in his recovery phase and the results from his blood very heartening.
"We decided to use a mixture of bone marrow and cord blood cells as it has a better and faster chance of success than only bone marrow cells. Bone marrow stem cells, on the other hand, could lead to Graft Versus Host Disease, triggered by the body's defense mechanism while the transfusion is being done. Not only increase the stem cell count, but also reduce the chance of any complications. It is the treatment of choice in such cases and leads to a complete cure," explained Dr Mukherjee, Medical Director of NetajiSubhash Chandra Bose Cancer Research Institute.
Source: The Telegraph, 7 May 2011

Justin
Justin (alias) was diagnosed with a common childhood cancer, neuroblastoma, at a tender age of one and half years old. Over the course of 1 year, the child had to endure numerous rounds of high-dose chemotherapy to treat his condition. Chemotherapy destroyed cancer cells, but at the same time also killed normal cells. Fortunately, Justin’s parents had his cord blood stored at birth with CordLife. The cord blood stem cells were infused back to his body after a course of chemotherapy in January 2011 at Queen Mary Hospital and he was discharged from hospital after 3 months. The cord blood unit used had been cryopreserved in our Hong Kong facility for 29 months. CordLife is very proud to achieve this milestone in the cord blood banking industry in Hong Kong.

Georgia
An accident at birth 2.5 years ago deprived Baby Georgia of oxygen to her brain, resulted in cerebral palsy. The damage to the toddler's brain caused her to move involuntarily, suffer from muscle spasms and have up to 50 seizures a day. It was only after CordLife put the family in touch with a renowned neurosurgeon that enable Georgia to be infused with her own cord blood, also stored by CordLife. Her conditions have improved since then.
"Georgia has made good progress since her stem cell infusion. She has better visual focus and eye contact with adults during play. She has more vocalization and tries to 'sing-a-song' by making different sounds to nursery rhymes. Georgia has improved postural and head control and is observed to be reaching more with her arms," said Ms. Jaclyn Tan, Consultant Occupational Therapist at OzWorks Therapy.
Source: The Sun, 3 December 2009

Lucas - Chronic Myeloid Leukaemia
Lucas (alias), a young boy was active and normal until he turned 10 years old and he was constantly lethargic and had a poor appetite for no reason. He also had significant weight loss with bouts of fever and vomiting and had to go through months of seeking treatments in numerous hospitals in Malaysia. In 2017, he was finally diagnosed by doctors that he had chronic myeloid leukaemia. Thankfully, Lucas’s parents managed to find a match in his younger brother’s cord blood, which they had stored at birth with Stemlife (A subsidiary of Cordlife Group Limited). The transplant took place successfully in 2018 and he is in remission currently.

Jason
When Jason was five years old, his mother noticed that he was having trouble walking, and a subsequent examination revealed that he had neuroblastoma. Neuroblastoma is a form of childhood cancer that affects the nervous system of infants and children younger than five years old. During the initial stages of treatment, doctors at Queen Mary Hospital removed a portion of Jason's adrenal tissue and then administered a series of radiation and drug treatments.
When Jason's doctors learned that his parents had stored his cord blood with HealthBaby Hong Kong at the time of his birth, they recommended that he undergo a stem cell transplant using his own cord blood to repair damaged cells and restore haematopoietic and immune functions. The doctors evaluated and confirmed that Jason's cord blood unit is of adequate quality and quantity, and they believe that using cord blood in the transplant will yield better results than using bone marrow. Thankfully, the stem cell transplant was a success, which improved Jason's overall treatment success and long-term survival. After a year of observation following the transplant, doctors confirmed that Jason no longer had cancer cells in his body.
Not expecting it to be used in such a life-threatening situation, Jason's mother felt relieved to have made the right decision to store his cord blood. She and her husband hope that by speaking out, more expectant parents will become aware of the lifesaving benefits of cord blood, which can potentially be used to treat over 80 diseases, including certain cancers, blood disorders, and genetic disorders.
Sepax®2 Maximises Cell Recovery to Increase Transplant Success FIRST in Singapore
Automated Stem Cell Processing System - The Standard in Cord Blood Banking
Stem cell isolation is a critical step in cord blood banking. It affects the number of stem cells that can be harvested or recovered from the cord blood. Cell recovery rates are critical because a higher number of stem cells could enhance the success of the transplant or treatment. That's why Cordlife has invested in the Sepax®2 automated stem cell processing technology, a safe, sterile and fully automated cord blood processing technology - so you get more stem cells for maximum transplant success*.
Sepax®2 versus other processing methods
The first private cord blood bank in Singapore that offers the Sepax®2 automated processing technology, this Swiss-made and U.S. FDA-cleared device can recover as high as 99.88%1 of Total Nucleated Cells (TNC) from cord blood. It is also a functionally closed processing system which ensures the sterility of the cord blood by eliminating exposure to air contaminants.

Feature | Benefits to You |
Swiss Quality
|
We process your baby's cord blood with high Swiss precision, reliable, state-of-the-art technology. |
Fully Automated
|
The yield from cord blood processing is consistent, with reproducible high results (that is, cell recoveries). |
Cell Recovery
|
More cells are recovered / harvested from your baby's cord blood for future treatment (if needed), allowing better chance of a successful transplant. |
Safety
|
Processing of your baby's cord blood unit is safe and highly sterile, leaving zero opportunity for error. |
Unique
|
Prevent any sample mix-up and eliminates any possible cross-contamination of your baby's precious cord blood unit. |
Regulatory Approvals
|
Meets international health, safety and environmental requirements to ensure consumer safety. |
Statistics/Evidence
|
Proven technology, equipment and consumables that are used by industry leader - the true validation on the quality of the Sepax® automated processing technology. |
First Bank
|
Our investment in advance technology now and in the future means you and your family will benefit from any future technology upgrade for the long-term storage of your baby's stem cells |
- Cordlife umbilical cord blood processing data as at 28 April 2015
- Biosafe, manufacturer of Sepax® (figures accurate as of 31 March 2013)
*Kindly note that the above mentioned is general information only. Please refer to the Cordlife Service Agreement for full details and its terms and conditions. Cordlife Group Limited reserves the rights to amend or cancel any of the benefits listed above without prior notice. International quality standards may differ between the time of enrolment and time of release of your baby's cord blood unit for transplant. All reasonable efforts will be made to adhere to the prevailing standards at the time of release of your baby's cord blood unit. HLA testing and CFU Assay may or may not cease to become a mandatory quality check.Cordlife has taken added insurance coverage, to safeguard you and your family from financial loss that results from direct malpractice*.
Maximizing the recovery of Total Nucleated Cells (TNC) from your child's precious cord blood is one part of the equation. The next crucial step is ensuring that the cells are carefully prepared for cryopreservation so that they can be stored indefinitely while retaining its viability for treatment purposes.
Cordlife is the first family cord blood bank in Singapore to adopt the Smart-Max™ technology - a fully automated cryoprotectant infuser, mixer and cooling device that allows for the consistent preparation of stem cells for cryopreservation. Unlike other devices that require manual handling, this Swiss-made device has high precision and is the epitome of reliability and quality.
The razor sharp precision of Smart-Max™ injects cryoprotectant at a constant and pre-defined temperature without any deviation in protocol. This mixes the cryoprotectant homogeneously with the stem cells without the need for human interference, thus averting any chance of human error. This ensures that the quality of the stem cells is maintained as they are placed into the liquid nitrogen storage systems at below -150°C.
With this implementation of Smart-Max™ , Cordlife's cord blood processing is now fully automated from receipt to storage, therefore ensuring that your child's cord blood is well protected.
Feature | Benefits to You |
Closed System | Guarantees that the cord blood is sterile and safe from external contaminants and bacteria |
Fully automated processing | Conducts the processing in a reproducible system, therefore ensuring consistent and high quality blood treatment |
All-in-one | Every procedure performed by Smart-Max™ is monitored by one programme, thus enabling a consistent level of protection at every step of processing |
User-friendly interface | Hands-free and simple to handle, thus minimizing the margin of any human error in processing |
Enhanced traceability features | Specific storage and data transfer functions ensure complete traceability of each unit |

Runner-Up In The Mid And Small Category
Of The 16th SIAS Investors’ Choice Awards
2015

Cordlife Honoured As One Of Forbes Asia’ s
2015 “Best Under a Billion” Companies

2015 Frost & Sullivan Singapore Stem Cell Banking Company of the Year Award

Baby Kingdom
Top 10 Family Brand Award, 2015

Capital Weekly
The Best Performance Company Awards 2013

Hong Kong Economic Times
2013 BABY & KID BRANDS AWARD

Securities Investors Association (Singapore)
14th SIAS Investors’ Choice Awards
2013 Most Transparent Company Award

The Hong Kong Council of Social Service
Caring Company 2011/12

Baby-Kingdom
Top 10 Family Brand Award 2013

Baby-Kingdom
Top 10 Family Brand Award 2012

GS1 Hong Kong
Consumer Caring 2011

Baby-Kingdom
Top 10 Family Brand Award 2011

Pregnancy Magazine
Top Pregnant, Baby Products Awards 2010 - 2013

Capital CEO Supreme Brand Awards 2010
Best Medical Service Award

Quamnet Outstanding Enterprise Awards
Outstanding Financial Strength Cord Blood Bank 2010 and 2011

TVB weekly The Most Popular Brand Award 2010 and 2011
The Most Popular Cord Blood Bank

Metro Radio
U Choice Lifestyle Brand 2010
Cord Blood Banking
Our Pledge to Quality Processing and Storage Standards

Cordlife assures you of a cord blood unit of suitable match or SG$50,000 to defray medical costs if the cord blood unit loses its viability at the point of transplant*.
Cord Lining Banking
The CellOptimaTM Assurance

Optimal Condition Assurance
Using CellOptima™ proprietary cell biomarker verification, your baby’s cord lining will be tested after 4 weeks of cryopreservation. During this process, sample segments of the frozen cord lining will be thawed and tested for cell viability and proliferation. This verification step is important as it helps ensure that your baby’s cord lining has been properly stored and can be used for future medical treatments. The objective of this process is to validate the following:
- Cell type(s) confirmation using MSC and/or EpSC biomarkers
- Cell viability
- Cell proliferation also known as the ability to multiply further
- Cord lining sterility
Quality Storage Assurance
Your baby’s cord lining will be stored in its original, unexpanded raw form. This ensures minimal manipulation that helps to retain the stem cells’ original characteristics and gives your family greater access to:
- The potential of harvesting other undiscovered cell types (besides MSC and EpSC)
- A higher purity of cells upon stem cell expansion
- Better stem cell expansion techniques in the future
*Terms & Conditions apply. Please refer to the Cordlife Service Agreement for full details.
Secure Storage
Singapore is an ideal long-term storage place for your baby's cord blood unit because of its natural disaster-free location, political and socio-economic stability.
Our facility at A'Posh Bizhub passed stringent audit conducted by Ministry of Health (MOH) Singapore as well as by AABB - so you can be assured of our strict adherence to national and international standards.

Your baby's cord blood will be stored in vacuum insulated cryogenic storage tanks housed inside fire retardant laboratory walls and are designed to remain at optimal temperature for cell storage over long periods. The tanks are monitored 24 hours a day, 365 days a year and our laboratory is also equipped with multiple backup systems to ensure continuous operation (undisrupted processing).
It is Cordlife's lifelong commitment to safeguard your baby's cord blood unit under the best storage conditions in the most secure and safest place. With your one chance, make that one right choice with Cordlife.

Here at Cordlife, we understand the concerns of you as a parent and the assurance of continued storage of your baby's cord blood.
In the very remote event that Cordlife Group Limited cease operations, Cordlife will assign your baby's cord blood to another provider of cord blood banking storage facilities that meets the necessary standards at the relevant time for licensing with the Ministry of Health (MOH) Singapore or of a comparable standard outside of Singapore.
This is our assurance to you for the long term storage of your baby's cord blood.
Here at Cordlife, we understand the concerns of you as a parent and the assurance of continued storage of your baby's cord blood.
In the very remote event that Cordlife Group Limited cease operations, Cordlife will assign your baby's cord blood to another provider of cord blood banking storage facilities that meets the necessary standards at the relevant time for licensing with the Ministry of Health (MOH) Singapore or of a comparable standard outside of Singapore.
This is our assurance to you for the long term storage of your baby's cord blood.
Cordlife is Singapore's private cord blood bank with published successful cord blood transplant and application track records.

Total Releases: 77

Autologous: 49

Allogeneic: 28

Cerebral Palsy: 19

Thalassaemia Major: 16

Autism Spectrum Disorder (ASD): 20

Leukaemia: 9
Neuroblastoma: 3
Brain Injury: 2
Hypoxic-Ischemic Encephalopathy: 3
Fanconi Anaemia: 1
Global Development Delay: 1
Sickle Cell Anaemia: 1
Developmental Dyspraxia: 1
Aplastic Anaemia: 1
The table below features the cord blood releases performed by Cordlife Group Limited and its subsidiaries. As a Group, Cordlife has made 76 cord blood releases, all of which have been used successfully in transplants or cellular therapy. This is the ultimate validation of our cord blood processing and storage capability.
NO | RELEASE | MEDICAL CONDITION | RECIPIENT'S RELATIONSHIP | STORAGE TIME (in months) | TREATMENT FACILITY |
---|
More...
Cordlife Cares
Providing private cord blood banking for the less privileged families.
Cordlife recognises that there are families who may benefit from cord blood banking but are financially challenged to do so. Obtaining a matching cord blood from the public source can cost as much as US$25,0001 and sometimes the search may be futile.
With Cordlife Cares, these families will have access to private cord blood banking, paid for by Cordlife. This means that eligible families will have genetically unique stem cells readily obtainable should a Haematopoietic Stem Cell (HSC) transplant be required.
Admission Criteria
- Singapore citizens or Singapore permanent residents
- Currently expecting a baby and delivering in Singapore
- Combined family monthly income below S$2,000
- Has an immediate family member who is/was diagnosed with a disease* currently treatable with cord blood stem cells.
Once accepted into the Cordlife Cares programme, Cordlife will provide the collection kit for the collection of cord blood. After the collection, the cord blood will be processed and stored until needed, without any cost to the family.
Should you wish to apply+ for this programme, or know of a family who may benefit from this programme, please call 6238 0808 or email cares@cordlife.com.
1 National Library Board Singapore website . Accessed February 19, 2009.
* List of diseases treated can be found at www.cordlife.com/sg/treatablediseases
+ Cordlife reserves the right to assess eligibility and subsequent enrolment into the Cordlife Cares programme
Cordlife is hiring! Do you have what it takes to be a Cordlifer?
We are inviting high calibre candidates to join our dynamic and passionate team in Singapore. With over 50,000 families (and growing) saving their babies' cord blood with Cordlife Group Limited, this is a fantastic opportunity to be part of a healthcare organisation that is fast-expanding!
Be part of our dynamic team!
Comprehensive training and development, remuneration package and staff benefits will be provided to the successful candidates.
We welcome Singaporeans and Singapore PRs to apply.
Kindly send your resume to:
Human Resources Department
Cordlife Group Limited
1 Yishun Industrial Street 1
#06-01/09
A'Posh Bizhub
Singapore 768160
Tel: (65) 6238 0808
Fax: (65) 6238 1108
Email: hr@cordlife.com
- Minimum qualification from O / A Levels or Polytechnic Diploma with at least 1 year experience in general administration
- Able to work within weekly deadlines
- Able to work well independently, as well as in a team
- Positive attitude, innovative and initiative
- Proficient in MS Office applications, i.e. Words, Excel and PowerPoint
- Sorting of materials in accordance with the existing filing system
- Preparation and upkeep of current records and documents
- Ensure documents are properly archived and placed
- Scanning and filing of documents
- Perform accurate data entry of contract and timely submission of finance forms
- Perform data integrity verification
- Update and acknowledgement of change of details and birth certificate
- Respond to email queries in a timely fashion
- Timely turnaround time for client correspondences
- Monitor and upkeep all borrowed Sales contracts in a log book
- Any miscellaneous changes on Singapore Sales contracts
- Franking of mails
- Maintain safety stock
- Any other duties that may be assigned by line manager from time to time
- Min Diploma with at least 2 years’ experience in digital media and social media marketing
- Strong communication and analytical skills
- Experience in working with agencies (ie: media, creative, etc.)
- Team player with strong project management skills, yet possesses the ability to work both independently with minimal supervision
- Support the Line Manager in the execution of marketing initiatives (events management, roll out of tactical promotions and brand campaigns, management of loyalty & referral programs, development of marketing materials, etc.)
- Participate in team brainstorming sessions and assist in the execution of all marketing initiatives / plans / strategies
- Rotational lead and support functions in the management of events (ie: baby fairs, seminars, client nurturing events, etc.)
- End-to-end execution and management of marketing campaigns – from content generation and copywriting, to campaign tracking and reporting
- Source, manage and liaise with agencies and vendors to develop marketing materials (e.g. product brochures, detailing aids, website content, etc.)
- Assist in marketing operations support (ie: expense reporting, raising of purchase orders, etc.)
- Basic salary + Attractive Staff Benefits
- Working location at Yishun
- Company Transport at Yishun, Bishan and Sengkang MRT Stations
- Career progression and opportunities for professional and personal development
- Comprehensive on-the-job and continuous trainings
- Friendly working environment
- Mim ‘O’ Level with at least 2 years’ experience
- Able to work independently and without close supervision
- Possess excellent interpersonal, communication and organization skills
- Meticulous and well-organized, with multi-tasking abilities
- Source for competitive quotes and inventory management
- Ensure all items purchased and received according to specifications
- Responsible for all purchasing and logistics
- Safe keep of all purchase orders, delivery orders & invoices before submission for approval & payment.
- To ensure all purchase order and delivery order/invoice are tally.
- To report all doubtful purchases & without documentation.
- Issuing of purchase order
- Managing laboratory supplier requalification, annual review and related
- Receiving, inspecting and issuing of laboratory materials
- Understanding and working knowledge of Good Distribution Practice for Medical Device in Singapore (GDPMDS)
- Assist to ensure all travel arrangement to follow company policy
- Basic salary + Attractive Staff Benefits
- Working location at Yishun
- Company Transport at Yishun, Bishan and Sengkang MRT Stations
- Career progression and opportunities for professional and personal development
- Comprehensive on-the-job and continuous trainings
- Friendly working environment
- Ensure that UCB (Umbilical Cord Blood) and UCL (Umbilical Cord Lining) are collected from all maternity hospitals in Singapore and delivered timely to our laboratory for processing.
- Monitor maternal blood withdrawal within 48 hours when initial withdrawal is insufficient.
- Ensure accuracy and completeness of documents in collection kits
- Good understanding of the specific SOPs (Standard Operating Procedures) and be able to carry out duties efficiently
- Call clients to acknowledge the receipt of UCB and UCL from the hospital
- Directly responsible for the laboratory processing and storage preparation of client's UCB and UCL
- Assist in the maintenance of quality in the laboratory
- Recognize protocol deviances and dutifully record incidences when necessary
- Any other duties that may be assigned by the line manager from time to time
- Diploma in Medical Technology or related disciplines
- Good aseptic technique, experience in tissue / plant culture and the handling of liquid nitrogen will be an added advantage.
- Experience in maintaining quality records will be an added advantage
- Strong sense of responsibility and a good team player
- Able to work independently and without supervision
- Keen interest to developing a career in the laboratory/ biotechnology field
- Effective communicator, both verbally and in writing in English
- Willing to work on weekends
- Basic salary + Attractive Staff Benefits
- Working location at Yishun
- Company Transport at Yishun, Bishan and Sengkang MRT Stations
- Career progression and opportunities for professional and personal development
- Comprehensive on-the-job and continuous trainings
- Friendly working environment
- Manage and maintain all installed infrastructure systems, network systems and application infrastructure
- Install, configure, test and maintain operating systems, application software and system management tools
- Proactively ensure the highest levels of systems and infrastructure availability
- Monitor and test application performance for potential bottlenecks, identify possible solutions and work with application team to implement fixes
- Manage and maintain backup and redundancy strategies
- Managing client workstations
- Managing mobile devices
- Maintain and review IT documentation
- Source and purchase IT equipment
- Respond to and resolve support requests
- Manage email servers
- Deliver training to users
- Participate in IT Auditing / Accreditation / ISO
- Backup as Helpdesk
- Min Diploma or similar with at least 3 years relevant experience
- Technical Skill
- Strong Microsoft Server (Install, Configure & Maintain, Migrate & Upgrade, Patching and the following)
- MS AD (Install, Manage and Design)
- GPO
- Windows Patches
- MSCE Certification
- Manage Group Printers
- Managing Microsoft Dynamics CRM (Install, Configure & Maintain, Migrate & Upgrade, Patching and the following)
- Managing Microsoft Dynamics NAV (Install, Configure & Maintain, Migrate & Upgrade, Patching and the following)
- Managing SAP B1 (Install, Configure & Maintain, Migrate & Upgrade, Patching and the following)
- Managing NAS Server
- Managing VOIP System
- Managing Backup Solution
- Office IT Equipment, CCTV, Door Access, Lab equipment
- Strong Networking experience include TCP/IP, networking, VPN, firewall & switches
- Strong Applications experience
- Microsoft Office (Install, Configure & Maintain)
- Microsoft Outlook setup
- Endpoint / Antivirus -Symantec / FortiClient
- FortiClient VPN Client
- Mobile Management - Android Phone / iPhone / Blackberry (Factory Reset, Setup Email, Install Apps)
- Strong Microsoft Server (Install, Configure & Maintain, Migrate & Upgrade, Patching and the following)
- Good initiative – initial meeting and discuss with users
- Proactive, interested in and able to find solutions, able to work within a team. / Hands-on attitude towards work
- Team-oriented – ability to work with different user groups
- Flexible - Responds positively to changes in procedures, processes, technologies, responsibilities or assignments, adapts and maintains a consistent level of effectiveness.
- Good Communication skills and ability to multitask
- Positive attitude
- Responsibility & Responsiveness – to ensure task will be completed within the timeline
- Ability to plan and do scheduling
- Basic salary + Attractive Staff Benefits
- Working location at Yishun
- Company Transport at Yishun, Bishan and Sengkang MRT Stations
- Career progression and opportunities for professional and personal development
- Comprehensive on-the-job and continuous trainings
- Friendly working environment
- Minimum qualification from ‘O’ / ‘A’ Levels or Polytechnic Diploma with at least 1 year experience in general administration
- Able to work within weekly deadlines
- Able to work well independently, as well as in a team
- Positive attitude, innovative and initiative
- Proficient in MS Office applications, i.e. Words, Excel and PowerPoint
- Sorting of materials in accordance with the existing filing system
- Preparation and upkeep of current records and documents
- Ensure documents are properly archived and placed
- Scanning and filing of documents
- Perform accurate data entry of contract and timely submission of finance forms
- Perform data integrity verification
- Basic salary + Performance Bonus + Attractive Staff Benefits
- Company Transport at Yishun, Bishan and Sengkang MRT Stations
- Career progression and opportunities for professional and personal development
- Comprehensive on-the-job and continuous trainings
- Friendly working environment
- Minimum accounting certification with at least 2 years of relevant working experience
- Responsible and reliable
- Meticulous
- Experience in data entry into accounting systems
- Accounts Receivable billings
- Attend to enquiries from clients
- GIRO processing
- Follow up on outstanding bills
- Update invoice records in spreadsheets
- Process credit payments by clients
- Cover duties for receipting function
- All other administrative and ad-hoc matters relating to AR cycle
- Diploma with minimum 1 year Customer Service / Telemarketing experience
- Highly independent and organized
- Team player
- Positive attitude with a pleasant personality
- Excellent email communication and telephony etiquette
- Proficient in computer skills; CRM/ERP and Microsoft Office
- Client relation management knowledge will be an added advantage
- Assist the Line Manager to maintain customer service excellence activities/programs.
- Provide support to enquiries on promotions, products and services
- Contribute to the Customer Care team in providing excellent after-sales support through various customer touch-point provide
- Instill customer loyalty and retain customers through the company's retention strategies
- Resolve customers complaint/ feedback and all difficult customer enquiries resulting in an increase in customer satisfaction and promotes customer retention.
Cordlife Group Limited
1 Yishun Industrial Street 1, #06-01/09 A'Posh Bizhub Singapore 768160Tel: (65) 6238 0808
Fax: (65) 6238 1108
Website: www.cordlife.com
Email: info@cordlife.com
Cordlife Sciences India Pvt. Ltd.
Corporate Identity Number: U85196WB2005PTC106719
Registered Office:
P.L. Deuty Road, off Diamond Harbour Road Bishnupur,
24 Parganas (S) West Bengal - 743503, India
Toll Free: 1800 345 6200
Tel: (91) 98 30166200
Fax: (91) 33 24809566
Cordlife Medical Philippines, Inc.
Unit 104 Building H UP-AyalaLand TechnoHub Commonwealth Ave. Bgy. UP Campus, Diliman Quezon City Philippines 1101
Mobiles: +63 998 848 6063 | +63 998 848 6064
Landlines : (02) 470 1735 | (02) 332 1888
Fax: (63) 2 3521304
Website: www.cordlife.com.ph
Email: info@ph.cordlife.com
P.T. Cordlife Persada
Corporate Office & Laboratory
Jalan Bungur Besar Raya No. 23
Gunung Sahari Selatan, Kemayoran
Central Jakarta, 10610 Indonesia
Tel: (+62) -21 8086-4674
Fax: (+62) -21 8086-4675
Email: info@id.cordlife.com
Cordlife (Hong Kong) Ltd.
Cordlife Stem Cell Technology Ltd.
Unit G15, G/F., Biotech Centre 2 No. 11 Science Park West Avenue Shatin New Territories, Hong Kong
Tel: (852) 3980 2980
Fax: (852) 25118882
Email: info@hk.cordlife.com
Cord Blood/Umblical Cord Collection Hotline:
(852) 3980 2999
Cordlife (Hong Kong) Ltd.
Suite 3603A, 36/F, Skyline Tower, 39 Wang Kwong Road, Kowloon Bay, Kowloon, Hong Kong
Contact Information:
Tel: (852) 3980 2888
Fax: (852) 25118882
Email: info@mo.cordlife.com
Cord Blood/Umblical Cord Collection Hotline: (852) 3980 2999
Cordlife (Macau)
Fleet Company Ltd. Rua De Coelho Do Amaral No. 91R/C, Macau
Tel: (853) 6881 0781
Fax: (853) 2835 2180
Email: info@mo.cordlife.com
StemLife Malaysia
B-7-15, Megan Avenue II,
12 Jalan Yap Kwan Seng,
50450 Kuala Lumpur, Malaysia
24hr Hotline: +603 2166 3636
Tel : +603 2163 8800
Fax : +603 2164 9808
Email: info@stemlife.com
Cordlife Myanmar
Marketed by BIO Secure Co., Ltd.
631 Pyay Road,
Kamaryut Township, Yangon
Myanmar 11041
24 Hour Hotline 09 2652 88882
Cordlife Vietnam
CMVN Joint Stock Company
The Official Marketing Agent of Cordlife Group Limited in Vietnam
Level 12, Minh Long Tower No. 17 Ba Huyen Thanh Quan,
Ward 6 District 3, Ho Chi Min City
24 Hour Hotline +84 98 355 1644
Email: info@vn.cordlife.com
Our laboratory and processes are approved and certified by the following authorities. We ensure that we have the best practices in cord blood stem cells collection and banking. They are timely checked and we are audited according to their stringent criteria to achieve our accreditation.

AABB Accreditation
(formerly known as the American Association of Blood Banks)The AABB has led the world in the development of blood banking standards since 1957. From 1991 onwards, the AABB has published standards for cord blood banking (which are updated regularly based on additional knowledge in the field), and these high standards are today recognised as the world's gold standards. These standards ensure that banks accredited by the AABB provide their customers with only the facts and the best possible method for processing as well as storing the transplant-ready cord blood units until needed in the future.
Cordlife Singapore has been accredited by AABB since 2005.
For more information on this standard, please visit AABB

FACT Accreditation
The Foundation for the Accreditation of Cellular Therapy (FACT) is the leader in international standards for cellular therapy. It is used in Europe, USA, Canada, Australia, and New Zealand.
FACT's standards for cord blood collection, processing, testing, banking and release are developed by highly-qualified scientists, technologists, clinicians and quality experts, who have the collective goal of pushing the boundaries of cellular therapy. Organizations bearing the FACT accreditation have earned it through the implementation of high-quality patient care and laboratory practices.
As of November 2015, Cordlife has been FACT accredited.
For more information on this standard, please visit FACT

Ministry of Health
Cordlife's facility in Singapore is licensed by Ministry of Health (MOH) Singapore for cord blood banking purposes. The facility is subject to regular inspections and audits which act as added assurance that each facility's highest and most stringent quality standards are consistently met, or exceeded.For more information on Ministry of Health (MOH) Singapore, please visit Ministry of Health (MOH) Singapore
Good Distribution Practice for Medical Devices in Singapore (GDPMDS) certification
Cordlife Group Limited was awarded the Good Distribution Practice for Medical Devices in Singapore (GDPMDS) certification in 2010.It ensures that the certified company has a quality management system, with procedures and facilities that adhere to the current good distribution practices.
This certification ensures Cordlife's Sepax® automated processing device and products are being consistently stored and handled in a quality manner during storage and transportation.
For more information, please visit Health Sciences Authority